Outbreak of Staphylococcus hominis subsp. novobiosepticus bloodstream infections in São Paulo city, Brazil

References

1. Bannerman T. L. 2003; Staphylococcus , Micrococcus , and other catalase-positive cocci that grow aerobically. In Manual of Clinical Microbiology pp 384–404 Edited by Murray P. R., Baron E. J., Jorgensen J. H., Pfaller M. A., Yolken R. H. Washington, DC: American Society for Microbiology;
   [Google Scholar]
2. Chaves F., García-Álvarez M., Sanz F., Alba C., Otero J. R. 2005; Nosocomial spread of a Staphylococcus hominis subsp. novobiosepticus strain causing sepsis in a neonatal intensive care unit. J Clin Microbiol 43:4877–4879 [CrossRef]
   [Google Scholar]
3. CLSI 2006 Performance Standards for Antimicrobial Susceptibility Testing , 16th information supplement, M100-S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. Hiramatsu K. 1998; Vancomycin resistance in staphylococci. Drug Resist Updat 1:135–150 [CrossRef]
   [Google Scholar]
5. Hussain Z., Stoakes L., Lannigan R., Longo S., Nancekivell B. 1998; Evaluation of screening and commercial methods for detection of methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol 36:273–274
   [Google Scholar]
6. Kloos W. E., George C. G., Olgiate J. S., van Pelt L., McKinnon M. L., Zimmer B. L., Müller E., Weinstein M. P., Mirrett S. 1998; Staphylococcus hominis subsp. novobiosepticus subsp. nov., a novel trehalose-and N -acetyl-d-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood cultures. Int J Syst Bacteriol 48:799–812 [CrossRef]
   [Google Scholar]
7. Pfaller M. A., Hollis R. J., Sader H. S. 1992; Molecular biology – PFGE analysis of chromosomal restriction fragments. In Clinical Microbiology Procedures Handbook pp. 10.5.c.110.5.c.11 Edited by Isenberg H. D. Washington, DC: American Society for Microbiology;
   [Google Scholar]
8. Pfaller M. A., Jones R. N., Doern G. V., Sader H. S., Kugler K. C., Beach M. L. The SENTRY Participants Group 1999; Survey of bloodstream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 33:283–297 [CrossRef]
   [Google Scholar]
9. Rupp M. E., Archer G. L. 1994; Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 19:231–245 [CrossRef]
   [Google Scholar]
10. Sader H. S., Gales A. C., Pfaller M. A., Mendes R. E., Zoccoli C., Barth A., Jones R. N. 2001; Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 5:200–214
    [Google Scholar]
11. Tenover F. C., Arbeit R. D., Goering R. V. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
    [Google Scholar]
12. Yamazumi T., Furuta I., Diekema D. J., Pfaller M. A., Jones R. N. 2001; Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol 39:3633–3636 [CrossRef]
    [Google Scholar]